TB subunit vaccines - Putting the pieces together

Microbes and Infection

Volumn 7, Issue 5-6, 2005, Pages 911-921

  Andersen, Peter ^a   Doherty, T Mark ^a  

^a STATENS SERUM INSTITUT   (Denmark)

Author keywords

Tuberculosis; Vaccines

Indexed keywords

AG 85A; AG 85B; AS 2 VACCINE; BACTERIAL ANTIGEN; BCG VACCINE; CFP 10; CFP 6; CORD FACTOR; DIPHTHERIA VACCINE; ESAT 6; GAMMA INTERFERON; HEPATITIS B VACCINE; HSPX ANTIGEN; IC 31 VACCINE; INTERLEUKIN 12; LIPOVAC VACCINE; LIVE VACCINE; LPPX ANTIGEN; MALARIA VACCINE; MPB 80; MPT 51; MPT 59; MPT 63; MPT 64; MPT 83; MT 3721; MTB 12; MTB 32A; MTB 39; MTB 39A; MTB 41; MTB 72F VACCINE; MTB 8.4; MTB 9.9; MURAMYL DIPEPTIDE; POLYPEPTIDE; PPE 68; PSTS 1; PSTS 2; PSTS 3; RV 0125; RV 0288; RV 0915C; RV 0928; RV 0932C; RV 0934; RV 1037C; RV 1174C; RV 1196; RV 1198; RV 1793; RV 1818C; RV 1886C; RV 1926C; RV 1980C; RV 2031C; RV 2376C; RV 2873; RV 2945C; RV 3004; RV 3407; RV 3619C; RV 3803C; RV 3804C; RV 3873; RV 3874; RV 3875; RV 3878; TB 10.4; TETANUS TOXOID; UNCLASSIFIED DRUG;

BIOCHEMISTRY; CLINICAL TRIAL; DRUG DELIVERY SYSTEM; GENOMICS; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOLOGY; INFECTION; MOLECULAR CLONING; MONITORING; MULTIGENE FAMILY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEOMICS; REVIEW; T LYMPHOCYTE ACTIVATION; TRANSCRIPTOMICS; VACCINE PRODUCTION;

MYCOBACTERIUM TUBERCULOSIS;

EID: 20444489482     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.micinf.2005.03.013     Document Type: Short Survey

References (131)

1. F.A. al-Kassimi, M.S. al-Hajjaj, and I.O. al-Orainey B. Ea, Does the protective effect of neonatal BCG correlate with vaccine-induced tuberculin reaction? Am. J. Respir. Crit. Care Med. 152 5 1995 1575 1578
2. J.A. Sterne, L.C. Rodrigues, and I.N. Guedes Does the efficacy of BCG decline with time since vaccination? Int. J. Tuberc. Lung Dis. 2 3 1998 200 207
3. C. Lanckriet, B.D. Levy, E. Bingono, R.M. Siopathis, and N. Guerin Efficacy of BCG vaccination of the newborn: evaluation by a follow-up study of contacts in Bangui Int. J. Epidemiol. 24 5 1995 1042 1049
4. G.A. Colditz, C.S. Berkey, F. Mosteller, T.F. Brewer, M.E. Wilson, E. Burdick, and H.V. Fineberg The efficacy of bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature Pediatrics 96 1 Pt. 1 1995 29 35
5. P.E. Fine Variation in protection by BCG: implications of and for heterologous immunity Lancet 346 1995 1339 1345
6. Anon Global Tuberculosis Control. WHO Report 2001 2001 World Health Organization Geneva, Switzerland p. 181
7. T.M. Doherty, and P. Andersen Tuberculosis vaccine development Curr. Opin. Pulm. Med. 8 3 2002 183 187
8. D.W. Smith Protective effect of BCG in experimental tuberculosis Adv. Tuberc. Res. 22 1985 1 97
9. I.M. Orme, D.N. McMurray, and J.T. Belisle Tuberculosis vaccine development: recent progress Trends Microbiol. 9 3 2001 115 118
10. U.E. Schaible, and S.H. Kaufmann CD1 molecules and CD1-dependent T cells in bacterial infections: a link from innate to acquired immunity? Semin. Immunol. 12 6 2000 527 535
11. A.M. Cooper, D.K. Dalton, T.A. Stewart, J.P. Griffin, D.G. Russell, and I.M. Orme Disseminated tuberculosis in interferon gamma gene-disrupted mice J. Exp. Med. 178 6 1993 2243 2247
12. S.E. Dorman, and S.M. Holland Interferon-gamma and interleukin-12 pathway defects and human disease Cytokine Growth Factor Rev. 11 4 2000 321 333
13. J.L. Flynn, J. Chan, K.J. Triebold, D.K. Dalton, T.A. Stewart, and B.R. Bloom An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection J. Exp. Med. 178 6 1993 2249 2254
14. R.R. Amara, and V. Satchidanandam Differential immunogenicity of novel Mycobacterium tuberculosis antigens derived from live and dead bacilli Infect. Immun. 65 11 1997 4880 4882
15. A.L. Sorensen, S. Nagai, G. Houen, P. Andersen, and A.B. Andersen Purification and characterization of a low-molecular-mass T-cell antigen secreted by Mycobacterium tuberculosis Infect. Immun. 63 5 1995 1710 1717
16. Y.A. Skeiky, P.J. Ovendale, S. Jen, M.R. Alderson, D.C. Dillon, S. Smith, C.B. Wilson, I.M. Orme, S.G. Reed, and A. Campos-Neto T cell expression cloning of a Mycobacterium tuberculosis gene encoding a protective antigen associated with the early control of infection J. Immunol. 165 12 2000 7140 7149
17. M.R. Alderson, T. Bement, C.H. Day, L. Zhu, D. Molesh, Y.A. Skeiky, R. Coler, D.M. Lewinsohn, S.G. Reed, and D.C. Dillon Expression cloning of an immunodominant family of Mycobacterium tuberculosis antigens using human CD4(+) T cells J. Exp. Med. 191 3 2000 551 560
18. A. Lalvani, R. Brookes, R.J. Wilkinson, A.S. Malin, A.A. Pathan, P. Andersen, H. Dockrell, G. Pasvol, and A.V. Hill Human cytolytic and interferon gamma-secreting CD8+ T lymphocytes specific for Mycobacterium tuberculosis Proc. Natl. Acad. Sci. USA 95 1 1998 270 275
19. C. Aagaard, I. Brock, A. Olsen, T.H. Ottenhoff, K. Weldingh, and P. Andersen Mapping immune reactivity toward Rv2653 and Rv2654: two novel low-molecular-mass antigens found specifically in the Mycobacterium tuberculosis complex J. Infect. Dis. 189 5 2004 812 819
20. I.M. Orme Induction of nonspecific acquired resistance and delayed-type hypersensitivity, but not specific acquired resistance in mice inoculated with killed mycobacterial vaccines Infect. Immun. 56 12 1988 3310 3312
21. R.L. Anacker, W.R. Barclay, W. Brehmer, G. Goode, R.H. List, E. Ribi, and D.F. Tarmina Effectiveness of cell walls of Mycobacterium bovis strain BCG administered by various routes and in different adjuvants in protecting mice against airborne infection with Mycobacterium tuberculosis strain H37Rv Am. Rev. Respir. Dis. 99 2 1969 242 248
22. S. Nagai, H.G. Wiker, M. Harboe, and M. Kinomoto Isolation and partial characterization of major protein antigens in the culture fluid of Mycobacterium tuberculosis Infect. Immun. 59 1 1991 372 382
23. P. Andersen, D. Askgaard, L. Ljungqvist, J. Bennedsen, and I. Heron Proteins released from Mycobacterium tuberculosis during growth Infect. Immun. 59 6 1991 1905 1910
24. R.D. Hubbard, C.M. Flory, and F.M. Collins Immunization of mice with mycobacterial culture filtrate proteins Clin. Exp. Immunol. 87 1 1992 94 98
25. P.G. Pal, and M.A. Horwitz Immunization with extracellular proteins of Mycobacterium tuberculosis induces cell-mediated immune responses and substantial protective immunity in a guinea pig model of pulmonary tuberculosis Infect. Immun. 60 11 1992 4781 4792
26. P. Andersen Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins Infect. Immun. 62 6 1994 2536 2544
27. P. Andersen, D. Askgaard, A. Gottschau, J. Bennedsen, S. Nagai, and I. Heron Identification of immunodominant antigens during infection with Mycobacterium tuberculosis Scand. J. Immunol. 36 6 1992 823 831
28. H. Boesen, B.N. Jensen, T. Wilcke, and P. Andersen Human T-cell responses to secreted antigen fractions of Mycobacterium tuberculosis Infect. Immun. 63 4 1995 1491 1497
29. P. Ravn, A. Demissie, T. Eguale, H. Wondwosson, D. Lein, H.A. Amoudy, A.S. Mustafa, A.K. Jensen, A. Holm, I. Rosenkrands, F. Oftung, J. Olobo, F. von Reyn, and P. Andersen Human T cell responses to the ESAT-6 antigen from Mycobacterium tuberculosis J. Infect. Dis. 179 3 1999 637 645
30. L. Brandt, T. Oettinger, A. Holm, A.B. Andersen, and P. Andersen Key epitopes on the ESAT-6 antigen recognized in mice during the recall of protective immunity to Mycobacterium tuberculosis J. Immunol. 157 8 1996 3527 3533
31. R.L. Skjøt, T. Oettinger, I. Rosenkrands, P. Ravn, I. Brock, S. Jacobsen, and P. Andersen Comparative evaluation of low-molecular-mass proteins from Mycobacterium tuberculosis identifies members of the ESAT-6 family as immunodominant T-cell antigens Infect. Immun. 68 1 2000 214 220
32. R.L. Skjot, I. Brock, S.M. Arend, M.E. Munk, M. Theisen, T.H. Ottenhoff, and P. Andersen Epitope mapping of the immunodominant antigen TB10.4 and the two homologous proteins TB10.3 and TB12.9, which constitute a subfamily of the esat-6 gene family Infect. Immun. 70 10 2002 5446 5453
33. R.N. Coler, A. Campos-Neto, P. Ovendale, F.H. Day, S.P. Fling, L. Zhu, N. Serbina, J.L. Flynn, S.G. Reed, and M.R. Alderson Vaccination with the T cell antigen Mtb 8.4 protects against challenge with Mycobacterium tuberculosis J. Immunol. 166 10 2001 6227 6235
34. R.N. Coler, Y.A. Skeiky, T. Vedvick, T. Bement, P. Ovendale, A. Campos-Neto, M.R. Alderson, and S.G. Reed Molecular cloning and immunologic reactivity of a novel low molecular mass antigen of Mycobacterium tuberculosis J. Immunol. 161 5 1998 2356 2364
35. K. Miki, T. Nagata, T. Tanaka, Y.H. Kim, M. Uchijima, N. Ohara, S. Nakamura, M. Okada, and Y. Koide Induction of protective cellular immunity against Mycobacterium tuberculosis by recombinant attenuated self-destructing Listeria monocytogenes strains harboring eukaryotic expression plasmids for antigen 85 complex and MPB/MPT51 Infect. Immun. 72 4 2004 2014 2021
36. N. Dhiman, and G.K. Khuller Immunoprophylactic properties of 71-kDa cell wall-associated protein antigen of Mycobacterium tuberculosis H37Ra Med. Microbiol. Immunol. (Berl.) 186 1 1997 45 51
37. N. Dhiman, and G.K. Khuller Protective efficacy of mycobacterial 71-kDa cell wall associated protein using poly (dl-lactide-co-glycolide) microparticles as carrier vehicles FEMS Immunol. Med. Microbiol. 21 1 1998 19 28
38. D.C. Dillon, M.R. Alderson, C.H. Day, D.M. Lewinsohn, R. Coler, T. Bement, A. Campos-Neto, Y.A. Skeiky, I.M. Orme, A. Roberts, S. Steen, W. Dalemans, R. Badaro, and S.G. Reed Molecular characterization and human T-cell responses to a member of a novel Mycobacterium tuberculosis mtb39 gene family Infect. Immun. 67 6 1999 2941 2950
39. S.T. Cole, R. Brosch, J. Parkhill, T. Garnier, C. Churcher, D. Harris, S.V. Gordon, K. Eiglmeier, S. Gas, C.E. Barry 3rd, F. Tekaia, K. Badcock, D. Basham, D. Brown, T. Chillingworth, R. Connor, R. Davies, K. Devlin, T. Feltwell, S. Gentles, N. Hamlin, S. Holroyd, T. Hornsby, K. Jagels, A. Krogh, J. Mclean, S. Moule, L. Murphy, K. Oliver, J. Osborne, M.A. Quail, M.A. Rajandream, J. Rogers, S. Rutter, K. Seeger, J. Skelton, R. Squares, S. Squares, J.E. Sulston, K. Taylor, S. Whitehead, and B.G. Barrel Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence Nature 393 1998 537 544
40. M.A. Behr, M.A. Wilson, W.P. Gill, H. Salamon, G.K. Schoolnik, S. Rane, and P.M. Small Comparative genomics of BCG vaccines by whole-genome DNA microarray Science 284 5419 1999 1520 1523
41. S.V. Gordon, R. Brosch, A. Billault, T. Garnier, K. Eiglmeier, and S.T. Cole Identification of variable regions in the genomes of tubercle bacilli using bacterial artificial chromosome arrays Mol. Microbiol. 32 3 1999 643 655
42. G.G. Mahairas, P.J. Sabo, M.J. Hickey, D.C. Singh, and C.K. Stover Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis J. Bacteriol. 178 1996 1274 1282
43. K.N. Lewis, R. Liao, K.M. Guinn, M.J. Hickey, S. Smith, M.A. Behr, and D.R. Sherman Deletion of RD1 from Mycobacterium tuberculosis mimics bacille Calmette-Guerin attenuation J. Infect. Dis. 187 1 2003 117 123
44. A.S. Pym, P. Brodin, R. Brosch, M. Huerre, and S.T. Cole Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti Mol. Microbiol. 46 3 2002 709 717
45. T. Hsu, S.M. Hingley-Wilson, B. Chen, M. Chen, A.Z. Dai, P.M. Morin, C.B. Marks, J. Padiyar, C. Goulding, M. Gingery, D. Eisenberg, R.G. Russell, S.C. Derrick, F.M. Collins, S.L. Morris, C.H. King, and W.R. Jacobs Jr. The primary mechanism of attenuation of bacillus Calmette-Guerin is a loss of secreted lytic function required for invasion of lung interstitial tissue Proc. Natl. Acad. Sci. USA 100 21 2003 12420 12425
46. F.X. Berthet, P.B. Rasmussen, I. Rosenkrands, P. Andersen, and B. Gicquel A Mycobacterium tuberculosis operon encoding ESAT-6 and a novel low-molecular-mass culture filtrate protein (CFP-10) Microbiology 144 1998 3195 3203
47. E.M. Agger, I. Brock, L.M. Okkels, S.M. Arend, C.S. Aagaard, K.N. Weldingh, and P. Andersen Human T-cell responses to the RD1-encoded protein TB27.4 (Rv3878) from Mycobacterium tuberculosis Immunology 110 4 2003 507 512
48. L.M. Okkels, I. Brock, F. Follmann, E.M. Agger, S.M. Arend, T.H. Ottenhoff, F. Oftung, I. Rosenkrands, and P. Andersen PPE protein (Rv3873) from DNA segment RD1 of Mycobacterium tuberculosis: strong recognition of both specific T-cell epitopes and epitopes conserved within the PPE family Infect. Immun. 71 11 2003 6116 6123
49. X.Q. Liu, D. Dosanjh, H. Varia, K. Ewer, P. Cockle, G. Pasvol, and A. Lalvani Evaluation of T-cell responses to novel RD1- and RD2-encoded Mycobacterium tuberculosis gene products for specific detection of human tuberculosis infection Infect. Immun. 72 5 2004 2574 2581
50. T.M. Doherty, A. Demissie, J. Olobo, D. Wolday, S. Britton, T. Eguale, P. Ravn, and P. Andersen Immune responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 signal subclinical infection among contacts of tuberculosis patients J. Clin. Microbiol. 40 2 2002 704 706
51. A. Lalvani, A.A. Pathan, H. McShane, R.J. Wilkinson, M. Latif, C.P. Conlon, G. Pasvol, and A.V. Hill Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells Am. J. Respir. Crit. Care Med. 163 4 2001 824 828
52. K.M. Guinn, M.J. Hickey, S.K. Mathur, K.L. Zakel, J.E. Grotzke, D.M. Lewinsohn, S. Smith, and D.R. Sherman Individual RD1-region genes are required for export of ESAT-6/CFP-10 and for virulence of Mycobacterium tuberculosis Mol. Microbiol. 51 2 2004 359 370
53. S. Mostowy, C. Cleto, D.R. Sherman, and M.A. Behr The Mycobacterium tuberculosis complex transcriptome of attenuation Tuberculosis (Edinb.) 84 3-4 2004 197 204
54. T.M. Doherty, A.W. Olsen, L. van Pinxteren, and P. Andersen Oral vaccination with subunit vaccines protects animals against aerosol infection with Mycobacterium tuberculosis Infect. Immun. 70 6 2002 3111 3121
55. A.W. Olsen, A. Williams, L.M. Okkels, G. Hatch, and P. Andersen Protective effect of a tuberculosis subunit vaccine based on a fusion of antigen 85B and ESAT-6 in the aerosol guinea pig model Infect. Immun. 72 10 2004 6148 6150
56. Y. Yuan, D.D. Crane, and C.E. Barry 3rd Stationary phase-associated protein expression in Mycobacterium tuberculosis: function of the mycobacterial alpha-crystallin homolog J. Bacteriol. 178 15 1996 4484 4492
57. J. Mehrotra, and W.R. Bishai Regulation of virulence genes in Mycobacterium tuberculosis Int. J. Med. Microbiol. 291 2 2001 171 182
58. M.A. Florczyk, L.A. McCue, R.F. Stack, C.R. Hauer, and K.A. McDonough Identification and characterization of mycobacterial proteins differentially expressed under standing and shaking culture conditions, including Rv2623 from a novel class of putative ATP-binding proteins Infect. Immun. 69 9 2001 5777 5785
59. K. Honer zu Bentrup, and D.G. Russell Mycobacterial persistence: adaptation to a changing environment Trends Microbiol. 9 12 2001 597 605
60. J.A. Triccas, and B. Gicquel Life on the inside: probing Mycobacterium tuberculosis gene expression during infection Immunol. Cell Biol. 78 4 2000 311 317
61. Y. Yuan, D.D. Crane, R.M. Simpson, Y.Q. Zhu, M.J. Hickey, D.R. Sherman, and C.E. Barry The 16-kDa alpha-crystallin (Acr) protein of Mycobacterium tuberculosis is required for growth in macrophages Proc. Natl. Acad. Sci. USA 95 16 1998 9578 9583
62. C. Boon, R. Li, R. Qi, and T. Dick Proteins of Mycobacterium bovis BCG induced in the Wayne dormancy model J. Bacteriol. 183 8 2001 2672 2676
63. I.M. Monahan, J. Betts, D.K. Banerjee, and P.D. Butcher Differential expression of mycobacterial proteins following phagocytosis by macrophages Microbiology 147 Pt. 2 2001 459 471
64. R. Manganelli, M.I. Voskuil, G.K. Schoolnik, and I. Smith The Mycobacterium tuberculosis ECF sigma factor sigmaE: role in global gene expression and survival in macrophages Mol. Microbiol. 41 2 2001 423 437
65. D.R. Sherman, M. Voskuil, D. Schnappinger, R. Liao, M.I. Harrell, and G.K. Schoolnik Regulation of the Mycobacterium tuberculosis hypoxic response gene encoding alpha-crystallin Proc. Natl. Acad. Sci. USA 98 13 2001 7534 7539
66. M. Strong, T.G. Graeber, M. Beeby, M. Pellegrini, M.J. Thompson, T.O. Yeates, and D. Eisenberg Visualization and interpretation of protein networks in Mycobacterium tuberculosis based on hierarchical clustering of genome-wide functional linkage maps Nucleic Acids Res. 31 24 2003 7099 7109
67. N.C. Gey Van Pittius, J. Gamieldien, W. Hide, G.D. Brown, R.J. Siezen, A.D. Beyers, The ESAT-6 gene cluster of Mycobacterium tuberculosis and other high G + C Gram-positive bacteria. Genome Biol. 2 (10) (2001) RESEARCH0044.
68. F. Tekaia, S.V. Gordon, T. Garnier, R. Brosch, B.G. Barrell, and S.T. Cole Analysis of the proteome of Mycobacterium tuberculosis in silico Tuber. Lung Dis. 79 6 1999 329 342
69. M.J. Pallen The ESAT-6/WXG100 superfamily - and a new Gram-positive secretion system? Trends Microbiol. 10 5 2002 209 212
70. L.A.H. van Pinxteren, P. Ravn, E.M. Agger, J.M. Pollock, and P. Andersen Diagnosis of tuberculosis based on the two specific antigens ESAT-6 and CFP10 Clin. Diagn. Lab. Immunol. 7 2000 155 160
71. L.M. Okkels, and P. Andersen Protein-protein interactions of proteins from the ESAT-6 family of Mycobacterium tuberculosis J. Bacteriol. 186 8 2004 2487 2491
72. K.L. Lightbody, P.S. Renshaw, M.L. Collins, R.L. Wright, D.M. Hunt, S.V. Gordon, R.G. Hewinson, R.S. Buxton, R.A. Williamson, and M.D. Carr Characterisation of complex formation between members of the Mycobacterium tuberculosis complex CFP-10/ESAT-6 protein family: towards an understanding of the rules governing complex formation and thereby functional flexibility FEMS Microbiol. Lett. 238 1 2004 255 262
73. P.S. Renshaw, P. Panagiotidou, A. Whelan, S.V. Gordon, R.G. Hewinson, R.A. Williamson, and M.D. Carr Conclusive evidence that the major T-cell antigens of the Mycobacterium tuberculosis complex ESAT-6 and CFP-10 form a tight, 1:1 complex and characterization of the structural properties of ESAT-6, CFP-10, and the ESAT-6*CFP-10 complex. Implications for pathogenesis and virulence J. Biol. Chem. 277 24 2002 21598 21603
74. R.J. Howard Vaccination against malaria: recent advances and the problems of antigenic diversity and other parasite evasion mechanisms Int. J. Parasitol. 17 1 1987 17 29
75. M.I. Voskuil, D. Schnappinger, R. Rutherford, Y. Liu, and G.K. Schoolnik Regulation of the Mycobacterium tuberculosis PE/PPE genes Tuberculosis (Edinb.) 84 3-4 2004 256 262
76. L. Ramakrishnan, N.A. Federspiel, and S. Falkow Granuloma-specific expression of Mycobacterium virulence proteins from the glycine-rich PE-PGRS family Science 288 5470 2000 1436 1439
77. M.J. Brennan, G. Delogu, Y. Chen, S. Bardarov, J. Kriakov, M. Alavi, and W.R. Jacobs Jr. Evidence that mycobacterial PE_PGRS proteins are cell surface constituents that influence interactions with other cells Infect. Immun. 69 12 2001 7326 7333
78. C. Espitia, J.P. Laclette, M. Mondragon-Palomino, A. Amador, J. Campuzano, A. Martens, M. Singh, R. Cicero, Y. Zhang, and C. Moreno The PE-PGRS glycine-rich proteins of Mycobacterium tuberculosis: a new family of fibronectin-binding proteins? Microbiology 145 Pt. 12 1999 3487 3495
79. K.K. Singh, X. Zhang, A.S. Patibandla, P. Chien Jr., and S. Laal Antigens of Mycobacterium tuberculosis expressed during preclinical tuberculosis: serological immunodominance of proteins with repetitive amino acid sequences Infect. Immun. 69 6 2001 4185 4191
80. G. Delogu, and M.J. Brennan Comparative immune response to PE and PE_PGRS antigens of Mycobacterium tuberculosis Infect. Immun. 69 9 2001 5606 5611
81. C. Demangel, P. Brodin, P.J. Cockle, R. Brosch, L. Majlessi, C. Leclerc, and S.T. Cole Cell envelope protein PPE68 contributes to Mycobacterium tuberculosis RD1 immunogenicity independently of a 10-kDa culture filtrate protein and ESAT-6 Infect. Immun. 72 4 2004 2170 2176
82. A.S. De Groot, A. Bosma, N. Chinai, J. Frost, B.M. Jesdale, M.A. Gonzalez, W. Martin, and C. Saint-Aubin From genome to vaccine: in silico predictions, ex vivo verification Vaccine 19 31 2001 4385 4395
83. H.M. Dockrell, S. Brahmbhatt, B.D. Robertson, S. Britton, U. Fruth, N. Gebre, M. Hunegnaw, R. Hussain, R. Manandhar, L. Murillo, M.C. Pessolani, P. Roche, J.L. Salgado, E. Sampaio, F. Shahid, J.E. Thole, and D.B. Young A postgenomic approach to identification of Mycobacterium leprae-specific peptides as T-cell reagents Infect. Immun. 68 10 2000 5846 5855
84. W. Martin, H. Sbai, and A.S. De Groot Bioinformatics tools for identifying class I-restricted epitopes Methods 29 3 2003 289 298
85. A.S. De Groot, E.A. Bishop, B. Khan, M. Lally, L. Marcon, J. Franco, K.H. Mayer, C.C. Carpenter, and W. Martin Engineering immunogenic consensus T helper epitopes for a cross-clade HIV vaccine Methods 34 4 2004 476 487
86. H.J. Mollenkopf, L. Grode, J. Mattow, M. Stein, P. Mann, B. Knapp, J. Ulmer, and S.H. Kaufmann Application of mycobacterial proteomics to vaccine design: improved protection by Mycobacterium bovis BCG prime-Rv3407 DNA boost vaccination against tuberculosis Infect. Immun. 72 11 2004 6471 6479
87. E.B. Lindblad, M.J. Elhay, R. Silva, R. Appelberg, and P. Andersen Adjuvant modulation of immune response to tuberculosis sub-unit vaccines Infect. Immun. 65 2 1997 623 629
88. J.M. Brewer, M. Conacher, C.A. Hunter, M. Mohrs, F. Brombacher, and J. Alexander Aluminium hydroxide adjuvant initiates strong antigen-specific Th2 responses in the absence of IL-4- or IL-13-mediated signaling J. Immunol. 163 12 1999 6448 6454
89. A. Weinrich Olsen, L.A. van Pinxteren, L. Meng Okkels, P. Birk Rasmussen, and P. Andersen Protection of mice with a tuberculosis subunit vaccine based on a fusion protein of antigen 85B and ESAT-6 Infect. Immun. 69 5 2001 2773 2778
90. K. Lingnau, A. Egyed, C. Schellack, F. Mattner, M. Buschle, and W. Schmidt Poly-l-arginine synergizes with oligodeoxynucleotides containing CpG-motifs (CpG-ODN) for enhanced and prolonged immune responses and prevents the CpG-ODN-induced systemic release of pro-inflammatory cytokines Vaccine 20 29-30 2002 3498 3508
91. I.T. Ling, S.A. Ogun, P. Momin, R.L. Richards, N. Garcon, J. Cohen, W.R. Ballou, and A.A. Holder Immunization against the murine malaria parasite Plasmodium yoelii using a recombinant protein with adjuvants developed for clinical use Vaccine 15 1997 1562
92. Y.A. Skeiky, M.R. Alderson, P.J. Ovendale, J.A. Guderian, L. Brandt, D.C. Dillon, A. Campos-Neto, Y. Lobet, W. Dalemans, I.M. Orme, and S.G. Reed Differential immune responses and protective efficacy induced by components of a tuberculosis polyprotein vaccine, Mtb72F, delivered as naked DNA or recombinant protein J. Immunol. 172 12 2004 7618 7628
93. K.M. Lima, V.L. Bonato, L.H. Faccioli, I.T. Brandao, S.A. dos Santos, A.A. Coelho-Castelo, S.C. Leao, and C.L. Silva Comparison of different delivery systems of vaccination for the induction of protection against tuberculosis in mice Vaccine 19 25-26 2001 3518 3525
94. L. Holten-Andersen, T.M. Doherty, K.S. Korsholm, and P. Andersen Combination of the cationic surfactant dimethyl dioctadecyl ammonium bromide and synthetic mycobacterial cord factor as an efficient adjuvant for tuberculosis subunit vaccines Infect. Immun. 72 3 2004 1608 1617
95. L. Brandt, M. Elhay, I. Rosenkrands, E.B. Lindblad, and P. Andersen ESAT-6 subunit vaccination against Mycobacterium tuberculosis Infect. Immun. 68 2 2000 791 795
96. C. Foged, C. Arigita, A. Sundblad, W. Jiskoot, G. Storm, and S. Frokjaer Interaction of dendritic cells with antigen-containing liposomes: effect of bilayer composition Vaccine 22 15-16 2004 1903 1913
97. M. Owais, A.K. Masood, J.N. Agrewala, D. Bisht, and C.M. Gupta Use of liposomes as an immunopotentiating delivery system: in perspective of vaccine development Scand. J. Immunol. 54 1-2 2001 125 132
98. N.P. Goonetilleke, H. McShane, C.M. Hannan, R.J. Anderson, R.H. Brookes, and A.V. Hill Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guerin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara J. Immunol. 171 3 2003 1602 1609
99. F. Bowe, E.C. Lavelle, E.A. McNeela, C. Hale, S. Clare, B. Arico, M.M. Giuliani, A. Rae, A. Huett, R. Rappuoli, G. Dougan, and K.H. Mills Mucosal vaccination against serogroup B meningococci: induction of bactericidal antibodies and cellular immunity following intranasal immunization with NadA of Neisseria meningitidis and mutants of Escherichia coli heat-labile enterotoxin Infect. Immun. 72 7 2004 4052 4060
100. S. Peppoloni, P. Ruggiero, M. Contorni, M. Morandi, M. Pizza, R. Rappuoli, A. Podda, and G. Del Giudice Mutants of the Escherichia coli heat-labile enterotoxin as safe and strong adjuvants for intranasal delivery of vaccines Expert Rev. Vaccines 2 2 2003 285 293
101. M. Glode, L. Joffe, K. Reisinger, M. Blatter, S. Plotkin, B. Watson, L. Grossman, B. Asmar, M. Berry, and S. Starobin Safety and immunogenicity of acellular pertussis vaccine combined with diphtheria and tetanus toxoids in 17- to 24-month-old children Pediatr. Infect. Dis. J. 11 7 1992 530 535
102. D.A. Blumberg, C.M. Mink, J.D. Cherry, C. Johnson, R. Garber, S.A. Plotkin, B. Watson, G.A. Ballanco, R.S. Daum, and B. Sullivan Comparison of acellular and whole-cell pertussis-component diphtheria-tetanus-pertussis vaccines in infants. The APDT Vaccine Study Group J. Pediatr. 119 2 1991 194 204
103. G. Delogu, A. Li, C. Repique, F. Collins, and S.L. Morris DNA vaccine combinations expressing either tissue plasminogen activator signal sequence fusion proteins or ubiquitin-conjugated antigens induce sustained protective immunity in a mouse model of pulmonary tuberculosis Infect. Immun. 70 1 2002 292 302
104. H. Cai, X. Tian, X.D. Hu, Y.H. Zhuang, and Y.X. Zhu Combined DNA vaccines formulated in DDA enhance protective immunity against tuberculosis DNA Cell Biol. 23 7 2004 450 456
105. A.W. Olsen, P.R. Hansen, A. Holm, and P. Andersen Efficient protection against Mycobacterium tuberculosis by vaccination with a single subdominant epitope from the ESAT-6 antigen Eur. J. Immunol. 30 6 2000 1724 1732
106. A.S. Mustafa, F. Oftung, H.A. Amoudy, N.M. Madi, A.T. Abal, F. Shaban, I.R. Krands, and P. Andersen Multiple epitopes from the Mycobacterium tuberculosis ESAT-6 antigen are recognized by antigen-specific human T cell lines Clin. Infect. Dis. 30 Suppl. 3 2000 S201 S205
107. S. Morris, C. Kelley, A. Howard, Z. Li, and F. Collins The immunogenicity of single and combination DNA vaccines against tuberculosis Vaccine 18 20 2000 2155 2163
108. Q.M. Wang, S.H. Sun, Z.L. Hu, F.J. Zhou, M. Yin, C.J. Xiao, and J.C. Zhang Epitope DNA vaccines against tuberculosis: spacers and ubiquitin modulates cellular immune responses elicited by epitope DNA vaccine Scand. J. Immunol. 60 3 2004 219 225
109. C.C. Bergmann, Q. Yao, C.K. Ho, and S.L. Buckwold Flanking residues alter antigenicity and immunogenicity of multi-unit CTL epitopes J. Immunol. 157 8 1996 3242 3249
110. S.J. McConkey, W.H. Reece, V.S. Moorthy, D. Webster, S. Dunachie, G. Butcher, J.M. Vuola, T.J. Blanchard, P. Gothard, K. Watkins, C.M. Hannan, S. Everaere, K. Brown, K.E. Kester, J. Cummings, J. Williams, D.G. Heppner, A. Pathan, K. Flanagan, N. Arulanantham, M.T. Roberts, M. Roy, G.L. Smith, J. Schneider, T. Peto, R.E. Sinden, S.C. Gilbert, and A.V. Hill Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans Nat. Med. 9 6 2003 729 735
111. M.W. Borgdorff, K. Floyd, and J.F. Broekmans Interventions to reduce tuberculosis mortality and transmission in low- and middle-income countries Bull. World Health Organ. 80 3 2002 217 227
112. Anon Global Tuberculosis Control. WHO Report 2002 2002 World Health Organization Geneva, Switzerland p. 181
113. A. Tanghe, O. Denis, B. Lambrecht, V. Motte, T. van den Berg, and K. Huygen Tuberculosis DNA vaccine encoding Ag85A is immunogenic and protective when administered by intramuscular needle injection but not by epidermal gene gun bombardment Infect. Immun. 68 7 2000 3854 3860
114. H. McShane, R. Brookes, S.C. Gilbert, and A.V. Hill Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis Infect. Immun. 69 2 2001 681 686
115. J. Hess, and S.H. Kaufmann Live antigen carriers as tools for improved anti-tuberculosis vaccines FEMS Immunol. Med. Microbiol. 23 2 1999 165 173
116. M.A. Horwitz, and G. Harth A new vaccine against tuberculosis affords greater survival after challenge than the current vaccine in the guinea pig model of pulmonary tuberculosis Infect. Immun. 71 4 2003 1672 1679
117. G. Delogu, A. Howard, F.M. Collins, and S.L. Morris DNA vaccination against tuberculosis: expression of a ubiquitin-conjugated tuberculosis protein enhances antimycobacterial immunity Infect. Immun. 68 6 2000 3097 3102
118. C.G. Feng, T.J. Blanchard, G.L. Smith, A.V. Hill, and W.J. Britton Induction of CD8+ T-lymphocyte responses to a secreted antigen of Mycobacterium tuberculosis by an attenuated vaccinia virus Immunol. Cell Biol. 79 6 2001 569 575
119. P. Brodin, L. Majlessi, R. Brosch, D. Smith, G. Bancroft, S. Clark, A. Williams, C. Leclerc, and S.T. Cole Enhanced protection against tuberculosis by vaccination with recombinant Mycobacterium microti vaccine that induces T cell immunity against region of difference 1 antigens J. Infect. Dis. 190 1 2004 115 122
120. L. Majlessi, M.J. Rojas, P. Brodin, and C. Leclerc CD8+-T-cell responses of Mycobacterium-infected mice to a newly identified major histocompatibility complex class I-restricted epitope shared by proteins of the ESAT-6 family Infect. Immun. 71 12 2003 7173 7177
121. N. Caccamo, S. Meraviglia, C. La Mendola, S. Bosze, F. Hudecz, J. Ivanyi, F. Dieli, and A. Salerno Characterization of HLA-DR- and TCR-binding residues of an immunodominant and genetically permissive peptide of the 16-kDa protein of Mycobacterium tuberculosis Eur. J. Immunol. 34 8 2004 2220 2229
122. J.N. Agrewala, and R.J. Wilkinson Differential regulation of Th1 and Th2 cells by p91-110 and p21-40 peptides of the 16-kDa alpha-crystallin antigen of Mycobacterium tuberculosis Clin. Exp. Immunol. 114 3 1998 392 397
123. S. Bhaskar, S.P. Khanna, and R. Mukherjee Isolation, purification and immunological characterization of novel low molecular weight protein antigen CFP 6 from culture filtrate of M. tuberculosis Vaccine 18 25 2000 2856 2866
124. J.R. Webb, T.S. Vedvick, M.R. Alderson, J.A. Guderian, S.S. Jen, P.J. Ovendale, S.M. Johnson, S.G. Reed, and Y.A. Skeiky Molecular cloning, expression, and immunogenicity of MTB12, a novel low- molecular-weight antigen secreted by Mycobacterium tuberculosis Infect. Immun. 66 9 1998 4208 4214
125. R. Al-Attiyah, A.S. Mustafa, A.T. Abal, A.S. El-Shamy, W. Dalemans, and Y.A. Skeiky In vitro cellular immune responses to complex and newly defined recombinant antigens of Mycobacterium tuberculosis Clin. Exp. Immunol. 138 1 2004 139 144
126. Y.A. Skeiky, M.J. Lodes, J.A. Guderian, R. Mohamath, T. Bement, M.R. Alderson, and S.G. Reed Cloning, expression, and immunological evaluation of two putative secreted serine protease antigens of Mycobacterium tuberculosis Infect. Immun. 67 8 1999 3998 4007
127. A. Tanghe, P. Lefevre, O. Denis, S. D'Souza, M. Braibant, E. Lozes, M. Singh, D. Montgomery, J. Content, and K. Huygen Immunogenicity and protective efficacy of tuberculosis DNA vaccines encoding putative phosphate transport receptors J. Immunol. 162 2 1999 1113 1119
128. V. Rao, N. Dhar, and A.K. Tyagi Modulation of host immune responses by overexpression of immunodominant antigens of Mycobacterium tuberculosis in bacille Calmette-Guerin Scand. J. Immunol. 58 4 2003 449 461
129. T. Xue, E. Stavropoulos, M. Yang, S. Ragno, M. Vordermeier, M. Chambers, G. Hewinson, D.B. Lowrie, M.J. Colston, and R.E. Tascon RNA encoding the MPT83 antigen induces protective immune responses against Mycobacterium tuberculosis infection Infect. Immun. 72 11 2004 6324 6329
130. R.G. Hewinson, S.L. Michell, W.P. Russell, R.A. McAdam, and W.R. Jacobs Jr. Molecular characterization of MPT83: a seroreactive antigen of Mycobacterium tuberculosis with homology to MPT70 Scand. J. Immunol. 43 5 1996 490 499
131. R. Al-Attiyah, and A.S. Mustafa Computer-assisted prediction of HLA-DR binding and experimental analysis for human promiscuous Th1-cell peptides in the 24:kDa secreted lipoprotein (LppX) of Mycobacterium tuberculosis Scand. J. Immunol. 59 1 2004 16 24